The December 22 incident at Ayden Healthcare of Oregon involved Resident #263, a man with emphysema who requires moderate assistance with daily activities and uses both a walker and wheelchair. Federal inspectors observed Licensed Practical Nurse #652 give him his prescribed Symbicort inhaler at 10:02 A.M. and leave without instructing or encouraging him to rinse his mouth afterward.

Symbicort contains budesonide, an inhaled corticosteroid that can cause oral thrush and other mouth infections if residue remains after use. The manufacturer's 2018 instructions explicitly state users must "rinse their mouth out with water and spit the water out" after inhaling the medication.
LPN #652 confirmed to inspectors 13 minutes later that residents should rinse their mouths after using steroid inhalers. She acknowledged she had not offered or encouraged Resident #263 to do so.
The resident's medical record shows he was admitted with multiple complex conditions including emphysema, hypertension, viral hepatitis C, alcohol dependence, cocaine use, and toxic encephalopathy. His December assessment revealed cognitive impairment, making it unlikely he would remember to rinse his mouth on his own.
Resident #263 takes Symbicort twice daily, receiving 160-4.5 micrograms per dose through two puffs inhaled orally every 12 hours for shortness of breath. Without proper mouth rinsing after each dose, steroid residue accumulates in his mouth and throat.
Registered Nurse #660 told inspectors the same day that residents should rinse their mouths with water after using steroid inhalers, confirming the facility's staff knew the proper protocol.
The 90-bed facility's failure affected one of three residents inspectors reviewed for medication administration during a complaint investigation. The violation represents what inspectors classified as "minimal harm or potential for actual harm," though oral thrush infections can cause significant pain and difficulty swallowing in elderly patients.
Steroid inhalers like Symbicort suppress local immune responses in the mouth and throat, creating conditions where fungal infections thrive. Medical literature consistently shows mouth rinsing after inhaled steroid use reduces infection rates by removing medication residue from oral tissues.
For cognitively impaired residents like #263, nursing staff must actively encourage and assist with mouth rinsing since these patients often cannot remember or independently perform the safety step. The facility's medication administration protocol should have included this requirement as part of the standard procedure.
The inspection occurred during a complaint investigation, meaning someone had reported concerns about care at the facility to state regulators. Inspectors discovered the steroid inhaler violation as an "incidental finding" while investigating the original complaint.
Ayden Healthcare of Oregon operates under provider identification number 365453 and completed its plan of correction following the December 23 inspection. The facility must demonstrate to state surveyors that staff now consistently offer mouth rinses after administering inhaled steroids.
The violation highlights how seemingly minor oversights in medication administration can compound health risks for vulnerable nursing home residents. Resident #263's combination of cognitive impairment, multiple chronic conditions, and dependence on staff for daily care made the nurse's failure to follow manufacturer safety instructions particularly concerning.
Federal regulations require nursing homes to provide treatment according to physician orders and accepted standards of practice. The Symbicort manufacturer's clear instructions for mouth rinsing constitute part of those accepted standards, making the nurse's omission a regulatory violation.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Ayden Healthcare of Oregon from 2025-12-23 including all violations, facility responses, and corrective action plans.